Evidence map›Paper›PMID 29731704›Full record

ReviewFrontiers in neuroscience2018

Oxytosis/Ferroptosis-(Re-) Emerging Roles for Oxidative Stress-Dependent Non-apoptotic Cell Death in Diseases of the Central Nervous System.

Jan Lewerenz, Gamze Ates, Axel Methner, Marcus Conrad, Pamela Maher

Abstract readReview
In one paragraph

Review in Frontiers in neuroscience, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 159 papers.

0numbers the graph read from it
0cells of the map it votes in
159citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

159 citing papers in PubMed.

  1. Trial
  2. Oxidative stress in neurodegeneration: from a simple insult to a dynamic regulator.Redox report : communications in free radical research · 2026
    Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Ferroptosis and hearing loss: from molecular mechanisms to therapeutic interventions.Journal of enzyme inhibition and medicinal chemistry · 2025
    Review
  14. Intersection of HNeurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2025
    Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

99 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jan LewerenzDepartment of Neurology, Ulm University, Ulm, Germany.
Gamze AtesCellular Neurobiology Laboratory, The Salk Institute for Biological Studies, La Jolla, CA, United States.
Axel MethnerDepartment of Neurology, University Medical Center and Focus Program Translational Neuroscience of the Johannes Gutenberg-University Mainz, Mainz, Germany.
Marcus ConradInstitute of Developmental Genetics, Helmholtz Zentrum München, Neuherberg, Germany.
Pamela MaherCellular Neurobiology Laboratory, The Salk Institute for Biological Studies, La Jolla, CA, United States.

Funding

Modulation of the Innate Immune Response by Fisetin Derivatives for the Treatment of ADR44AI104034 · NIAID · VIROGENICS, INC. · PI RASCHKE, WILLIAM C · 2018 to 2020
$2.9M
Modulation of the Innate Immune Response by Fisetin Derivatives for the Treatment of ADR42AI104034 · NIAID · VIROGENICS, INC. · PI MAHER, PAMELA ANNE · 2016 to 2017
$1.5M
Modulation of the Innate Immune System by Fisetin for the Treatment of ADR41AI104034 · NIAID · VIROGENICS, INC. · PI MAHER, PAMELA ANNE · 2013 to 2014
$600k
NIAID NIH HHS R41 AI104034NIAID NIH HHS R42 AI104034NIAID NIH HHS R44 AI104034
6 · The paper itself

Abstract

Although nerve cell death is the hallmark of many neurological diseases, the processes underlying this death are still poorly defined. However, there is a general consensus that neuronal cell death predominantly proceeds by regulated processes. Almost 30 years ago, a cell death pathway eventually named oxytosis was described in neuronal cells that involved glutathione depletion, reactive oxygen species production, lipoxygenase activation, and calcium influx. More recently, a cell death pathway that involved many of the same steps was described in tumor cells and termed ferroptosis due to a dependence on iron. Since then there has been a great deal of discussion in the literature about whether these are two distinct pathways or cell type- and insult-dependent variations on the same pathway. In this review, we compare and contrast in detail the commonalities and distinctions between the two pathways concluding that the molecular pathways involved in the regulation of ferroptosis and oxytosis are highly similar if not identical. Thus, we suggest that oxytosis and ferroptosis should be regarded as two names for the same cell death pathway. In addition, we describe the potential physiological relevance of oxytosis/ferroptosis in multiple neurological diseases.

Indexed as

brain diseasesferroptosisironoxidative stressoxytosisprogrammed cell death

Identifiers

PMID29731704
PMCPMC5920049

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.